title: [Efficacy of telbivudine in blocking the vertical transmission and the safety observation of discontinuing treatment time after delivery on mother infected with HBV].
authors: Zhejiang Chinese Medical University Affliliated Sixth Hospital, Hangzhou Institute of Liver Diseases, China.
authors: Rong
authors: R
authors: Chen
authors: Shou-rong
authors: SR
authors: Liu
authors: Su-ying
authors: SY
authors: Zhang
authors: Cheng-jing
authors: CJ
authors: Tao
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D009035:Mothers; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D000077712:Telbivudine; D013936:Thymidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D000077712:Telbivudine; D013936:Thymidine